APO RESEARCH · REPORT
Immune Health Product
Immune health products are health products that can improve immunity and promote metabolism.
Product & engineering
Understand the product.
Immune health products are health products that can improve immunity and promote metabolism.
Selected research
Industry Research
Immune Health Product Industry Research Report 2026
Market perspective
Immune health products are health products that can improve immunity and promote metabolism.
Global Immune Health Product key players include Amway, Suntory, GNC, INFINITUS, Herbalife Nutrition, etc. Global top five manufacturers hold a share about 20%. North America is the largest market, with a share about 30%, followed by Europe and China, both have a share over 37 percent. In terms of product, Capsule/Pills is the largest segment, with a share over 81%. And in terms of End User, the largest End User is Adults, followed by Men, etc.
Report Scope
Read the full market overview
This report quantifies the global Immune Health Product market in terms of revenue (US$ million) and, where applicable, service volume (K Units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Immune Health Product.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Immune Health Product Market by Company
Amway
Suntory
GNC
INFINITUS
Herbalife Nutrition
USANA Health Sciences, Inc.
PERFECT
Nestlé SA
H&H Group
China New Era Group
By-health
Black Mores
Glanbia Plc
Nature’s
Real Nutriceutical
Immune Health Product Segment by Form
Capsule/Pills
Powder
Liquid
Immune Health Product Segment by End Users
Children/Teenagers
Men
Adults
The Elderly
Immune Health Product Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Immune Health Product market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Immune Health Product and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Immune Health Product.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Immune Health Product companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Capsule/Pills
- Powder
- Liquid
Applications
- Children/Teenagers
- Men
- Adults
- The Elderly
Companies covered
- Amway
- Suntory
- GNC
- INFINITUS
- Herbalife Nutrition
- USANA Health Sciences, Inc.
- PERFECT
- Nestlé SA
- H&H Group
- China New Era Group
- By-health
- Black Mores
- Glanbia Plc
- Nature’s
- Real Nutriceutical
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Immune Health Product by Form
- 2.2.1 Market Value Comparison by Form (2021 VS 2025 VS 2032)
- 2.2.2 Capsule/Pills
- 2.2.3 Powder
- 2.2.4 Liquid
- 2.3 Immune Health Product by End Users
- 2.3.1 Market Value Comparison by End Users (2021 VS 2025 VS 2032)
- 2.3.2 Children/Teenagers
- 2.3.3 Men
- 2.3.4 Adults
- 2.3.5 The Elderly
- 2.4 Assumptions and Limitations
3 Immune Health Product Breakdown Data by Form
- 3.1 Global Immune Health Product Historic Market Size by Form (2021-2026)
- 3.2 Global Immune Health Product Forecasted Market Size by Form (2027-2032)
4 Immune Health Product Breakdown Data by End Users
- 4.1 Global Immune Health Product Historic Market Size by End Users (2021-2026)
- 4.2 Global Immune Health Product Forecasted Market Size by End Users (2027-2032)
5 Global Growth Trends
- 5.1 Global Immune Health Product Market Perspective (2021-2032)
- 5.2 Global Immune Health Product Growth Trends by Region
- 5.2.1 Global Immune Health Product Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Immune Health Product Historic Market Size by Region (2021-2026)
- 5.2.3 Immune Health Product Forecasted Market Size by Region (2027-2032)
- 5.3 Immune Health Product Market Dynamics
- 5.3.1 Immune Health Product Industry Trends
- 5.3.2 Immune Health Product Market Drivers
- 5.3.3 Immune Health Product Market Challenges
- 5.3.4 Immune Health Product Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Immune Health Product Players by Revenue
- 6.1.1 Global Top Immune Health Product Players by Revenue (2021-2026)
- 6.1.2 Global Immune Health Product Revenue Market Share by Players (2021-2026)
- 6.2 Global Immune Health Product Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Immune Health Product Head Office and Area Served
- 6.4 Global Immune Health Product Players, Product Type & Application
- 6.5 Global Immune Health Product Manufacturers Established Date
- 6.6 Global Immune Health Product Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Immune Health Product Market Size (2021-2032)
- 7.2 North America Immune Health Product Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Immune Health Product Market Size by Country (2021-2026)
- 7.4 North America Immune Health Product Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Immune Health Product Market Size (2021-2032)
- 8.2 Europe Immune Health Product Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Immune Health Product Market Size by Country (2021-2026)
- 8.4 Europe Immune Health Product Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Immune Health Product Market Size (2021-2032)
- 9.2 Asia-Pacific Immune Health Product Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Immune Health Product Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Immune Health Product Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Immune Health Product Market Size (2021-2032)
- 10.2 South America Immune Health Product Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Immune Health Product Market Size by Country (2021-2026)
- 10.4 South America Immune Health Product Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Immune Health Product Market Size (2021-2032)
- 11.2 Middle East & Africa Immune Health Product Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Immune Health Product Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Immune Health Product Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Amway
- 12.1.1 Amway Company Information
- 12.1.2 Amway Business Overview
- 12.1.3 Amway Revenue in Immune Health Product Business (2021-2026)
- 12.1.4 Amway Immune Health Product Product Portfolio
- 12.1.5 Amway Recent Developments
- 12.2 Suntory
- 12.2.1 Suntory Company Information
- 12.2.2 Suntory Business Overview
- 12.2.3 Suntory Revenue in Immune Health Product Business (2021-2026)
- 12.2.4 Suntory Immune Health Product Product Portfolio
- 12.2.5 Suntory Recent Developments
- 12.3 GNC
- 12.3.1 GNC Company Information
- 12.3.2 GNC Business Overview
- 12.3.3 GNC Revenue in Immune Health Product Business (2021-2026)
- 12.3.4 GNC Immune Health Product Product Portfolio
- 12.3.5 GNC Recent Developments
- 12.4 INFINITUS
- 12.4.1 INFINITUS Company Information
- 12.4.2 INFINITUS Business Overview
- 12.4.3 INFINITUS Revenue in Immune Health Product Business (2021-2026)
- 12.4.4 INFINITUS Immune Health Product Product Portfolio
- 12.4.5 INFINITUS Recent Developments
- 12.5 Herbalife Nutrition
- 12.5.1 Herbalife Nutrition Company Information
- 12.5.2 Herbalife Nutrition Business Overview
- 12.5.3 Herbalife Nutrition Revenue in Immune Health Product Business (2021-2026)
- 12.5.4 Herbalife Nutrition Immune Health Product Product Portfolio
- 12.5.5 Herbalife Nutrition Recent Developments
- 12.6 USANA Health Sciences, Inc.
- 12.6.1 USANA Health Sciences, Inc. Company Information
- 12.6.2 USANA Health Sciences, Inc. Business Overview
- 12.6.3 USANA Health Sciences, Inc. Revenue in Immune Health Product Business (2021-2026)
- 12.6.4 USANA Health Sciences, Inc. Immune Health Product Product Portfolio
- 12.6.5 USANA Health Sciences, Inc. Recent Developments
- 12.7 PERFECT
- 12.7.1 PERFECT Company Information
- 12.7.2 PERFECT Business Overview
- 12.7.3 PERFECT Revenue in Immune Health Product Business (2021-2026)
- 12.7.4 PERFECT Immune Health Product Product Portfolio
- 12.7.5 PERFECT Recent Developments
- 12.8 Nestlé SA
- 12.8.1 Nestlé SA Company Information
- 12.8.2 Nestlé SA Business Overview
- 12.8.3 Nestlé SA Revenue in Immune Health Product Business (2021-2026)
- 12.8.4 Nestlé SA Immune Health Product Product Portfolio
- 12.8.5 Nestlé SA Recent Developments
- 12.9 H&H Group
- 12.9.1 H&H Group Company Information
- 12.9.2 H&H Group Business Overview
- 12.9.3 H&H Group Revenue in Immune Health Product Business (2021-2026)
- 12.9.4 H&H Group Immune Health Product Product Portfolio
- 12.9.5 H&H Group Recent Developments
- 12.10 China New Era Group
- 12.10.1 China New Era Group Company Information
- 12.10.2 China New Era Group Business Overview
- 12.10.3 China New Era Group Revenue in Immune Health Product Business (2021-2026)
- 12.10.4 China New Era Group Immune Health Product Product Portfolio
- 12.10.5 China New Era Group Recent Developments
- 12.11 By-health
- 12.11.1 By-health Company Information
- 12.11.2 By-health Business Overview
- 12.11.3 By-health Revenue in Immune Health Product Business (2021-2026)
- 12.11.4 By-health Immune Health Product Product Portfolio
- 12.11.5 By-health Recent Developments
- 12.12 Black Mores
- 12.12.1 Black Mores Company Information
- 12.12.2 Black Mores Business Overview
- 12.12.3 Black Mores Revenue in Immune Health Product Business (2021-2026)
- 12.12.4 Black Mores Immune Health Product Product Portfolio
- 12.12.5 Black Mores Recent Developments
- 12.13 Glanbia Plc
- 12.13.1 Glanbia Plc Company Information
- 12.13.2 Glanbia Plc Business Overview
- 12.13.3 Glanbia Plc Revenue in Immune Health Product Business (2021-2026)
- 12.13.4 Glanbia Plc Immune Health Product Product Portfolio
- 12.13.5 Glanbia Plc Recent Developments
- 12.14 Nature’s
- 12.14.1 Nature’s Company Information
- 12.14.2 Nature’s Business Overview
- 12.14.3 Nature’s Revenue in Immune Health Product Business (2021-2026)
- 12.14.4 Nature’s Immune Health Product Product Portfolio
- 12.14.5 Nature’s Recent Developments
- 12.15 Real Nutriceutical
- 12.15.1 Real Nutriceutical Company Information
- 12.15.2 Real Nutriceutical Business Overview
- 12.15.3 Real Nutriceutical Revenue in Immune Health Product Business (2021-2026)
- 12.15.4 Real Nutriceutical Immune Health Product Product Portfolio
- 12.15.5 Real Nutriceutical Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst